ALYSSA KJERULF: Open Payments
NPI 1730920026 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 29 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $270 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $245 |
| Janssen Biotech, Inc. | 3 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| UROGEN PHARMA, INC. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| Organon LLC | 1 | $30 |
| Endo USA, Inc. | 1 | $30 |
| TOLMAR, INC. | 1 | $28 |
| Becton, Dickinson and Company | 1 | $28 |
Products named: Nubeqa, ERLEADA, GEMTESA, JOURNAVX, AVEED, JATENZO, Magic3 Go Intermittent Urinary Catheter, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
